Psychiatry and Mental Health - Global Neurology Academy

Episodes 1-16 of 63

Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits
From Resistance to Response: Evolving Strategies in MDD Management
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast Replay
From Resistance to Response: Evolving Strategies in MDD Management
1.00 credit
- Joseph F. Goldberg, MD
1.00 credit
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiers
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
NeuroFrontiers
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
- John Golden
- Michael Greenberg, MD
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
NeuroFrontiers
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
- John Golden
- Michael Greenberg, MD
Mapping Brain Atrophy in Schizophrenia
Mapping Brain Atrophy in Schizophrenia
Neurology and Neurosurgery
Mapping Brain Atrophy in Schizophrenia
- Ahmed Makhlouf, MD
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Global Neurology Academy
Understanding Schizophrenia: Early Intervention and Prevention Strategies
- Joseph F. Goldberg, MD
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Global Neurology Academy
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
- Joseph F. Goldberg, MD
Genetics in Schizophrenia Management: Emerging Technological Strategies
Genetics in Schizophrenia Management: Emerging Technological Strategies
Psychiatry and Mental Health
Genetics in Schizophrenia Management: Emerging Technological Strategies
- Aaron Besterman, MD
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiers
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
- Ashley Baker, MSN, PMHNP
- Steven Paul, MD
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
- David Kimhy, PhD
Genetics and Schizophrenia: Key Ethical Considerations
Genetics and Schizophrenia: Key Ethical Considerations
NeuroFrontiers
Genetics and Schizophrenia: Key Ethical Considerations
- Aaron Besterman, MD
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiers
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
- Natalie Bareis, PhD, LMSW
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiers
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
- Natalie Bareis, PhD, LMSW
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Global Neurology Academy
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
- Steven Paul, MD
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiers
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
- Steven Paul, MD

Prev
1
2
3
4
Next

1/4